These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 33968060)

  • 21. HLA genetic polymorphism in patients with Coronavirus Disease 2019 in Midwestern United States.
    Schindler E; Dribus M; Duffy BF; Hock K; Farnsworth CW; Gragert L; Liu C
    HLA; 2021 Oct; 98(4):370-379. PubMed ID: 34338446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.
    Benden C; Haile S; Kruegel N; Beyeler F; Aubert JD; Binet I; Golshayan D; Hadaya K; Mueller T; Parvex P; Immer F
    Swiss Med Wkly; 2020 Dec; 150():w20451. PubMed ID: 33382903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19.
    Castro-Santos P; Rojas-Martinez A; Riancho JA; Lapunzina P; Flores C; Carracedo Á; Díaz-Peña R;
    HLA; 2023 Dec; 102(6):731-739. PubMed ID: 37528566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic study of KIR and HLA ligands in 235 individuals from Northeastern Thailand.
    Chaisri S; Leelayuwat C; Romphruk A
    Hum Immunol; 2017; 78(5-6):395-396. PubMed ID: 28431957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese.
    Seki SS; Sugimura K; Ota M; Matsuzawa J; Katsuyama Y; Ishizuka K; Mochizuki T; Suzuki K; Yoneyama O; Mizuki N; Honma T; Inoko H; Asakura H
    Tissue Antigens; 2001 Aug; 58(2):71-6. PubMed ID: 11696218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19.
    Nishida N; Sugiyama M; Kawai Y; Naka I; Iwamoto N; Suzuki T; Suzuki M; Miyazato Y; Suzuki S; Izumi S; Hojo M; Tsuchiura T; Ishikawa M; Ohashi J; Ohmagari N; Tokunaga K; Mizokami M
    Sci Rep; 2022 Mar; 12(1):3854. PubMed ID: 35264675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel allele, HLA-C*15:227, identified when typing COVID-19 patients.
    Cheranev V; Loginova M; Jankevic T; Kutyavina S; Rebrikov D
    HLA; 2021 Apr; 97(4):377-378. PubMed ID: 33539638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Severity of Takayasu Arteritis Is Associated with the HLA-B52 Allele in Japanese Patients.
    Origuchi T; Fukui S; Umeda M; Nishino A; Nakashima Y; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Kawakami A
    Tohoku J Exp Med; 2016 May; 239(1):67-72. PubMed ID: 27193038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan.
    Akiyama Y; Morioka S; Wakimoto Y; Kawashima A; Kanda K; Okuhama A; Suzuki T; Miyazato Y; Nomoto H; Ide S; Nakamoto T; Nakamura K; Ota M; Moriyama Y; Takaya S; Yamada K; Taguchi M; Sugito E; Izuka S; Ishiguro K; Kobayashi T; Miyake W; Kubota S; Ishikane M; Kinoshita N; Yamamoto K; Ujiie M; Kutsuna S; Hayakawa K; Saito S; Ohmagari N
    Intern Med; 2020 Dec; 59(24):3131-3133. PubMed ID: 33132334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.
    Sattler A; Angermair S; Stockmann H; Heim KM; Khadzhynov D; Treskatsch S; Halleck F; Kreis ME; Kotsch K
    J Clin Invest; 2020 Dec; 130(12):6477-6489. PubMed ID: 32833687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of patients with a previous endemic coronavirus infection during the COVID-19 pandemic.
    Otlu B; Yakupogullari Y; Tanriverdi ES; Bayindir Y
    J Med Virol; 2021 Jul; 93(7):4544-4548. PubMed ID: 33724483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection.
    Marchal A; Cirulli ET; Neveux I; Bellos E; Thwaites RS; Schiabor Barrett KM; Zhang Y; Nemes-Bokun I; Kalinova M; Catchpole A; Tangye SG; Spaan AN; Lack JB; Ghosn J; Burdet C; Gorochov G; Tubach F; Hausfater P; ; ; ; ; ; ; ; ; ; Dalgard CL; Zhang SY; Zhang Q; Chiu C; Fellay J; Grzymski JJ; Sancho-Shimizu V; Abel L; Casanova JL; Cobat A; Bolze A
    HGG Adv; 2024 Jul; 5(3):100300. PubMed ID: 38678364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics of Japanese patients with moderate to severe COVID-19.
    Otoshi R; Hagiwara E; Kitayama T; Yamaya T; Higa K; Murohashi K; Sato Y; Tabata E; Shintani R; Okabayashi H; Ikeda S; Niwa T; Nakazawa A; Oda T; Okuda R; Sekine A; Kitamura H; Baba T; Komatsu S; Ogura T
    J Infect Chemother; 2021 Jun; 27(6):895-901. PubMed ID: 33727024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.
    Ashish A; Unsworth A; Martindale J; Sundar R; Kavuri K; Sedda L; Farrier M
    BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33148777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
    Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
    Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.